ramatroban has been researched along with cilostazol in 1 studies
| Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) | Studies (cilostazol) | Trials (cilostazol) | Recent Studies (post-2010) (cilostazol) |
|---|---|---|---|---|---|
| 142 | 10 | 28 | 1,508 | 302 | 848 |
| Protein | Taxonomy | ramatroban (IC50) | cilostazol (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 10 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.4367 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.3285 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, J; Ayukawa, O; Iguro, Y; Kariyazono, H; Majima, HJ; Masuda, H; Nakamura, K; Onimaru, S; Sakata, R; Yamada, K | 1 |
1 other study(ies) available for ramatroban and cilostazol
| Article | Year |
|---|---|
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Carbazoles; Cilostazol; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Humans; Microscopy, Confocal; Phosphodiesterase Inhibitors; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Reproducibility of Results; Sulfonamides; Tetrazoles | 2004 |